26 May 2013
Keywords: sosei, out-licenses, mefloquine, treague, japanese, drug, firm
Article | 01 December 2008
Japanese drug firm Sosei Group has out-licensed its intellectual property and know-how relating to the RS(+) isomer of mefloquine to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
24 May 2013
© 2013 thepharmaletter.com